A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Public ClinicalTrials.gov record NCT01288911. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine the efficacy and safety of oral enzalutamide compared to bicalutamide in castrate men with metastatic prostate cancer who have progressed while on Luteinizing Hormone Receptor Hormone (LHRH) agonist/antagonist or after receiving a bilateral orchiectomy.
Study identification
- NCT ID
- NCT01288911
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 375 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 21, 2011
- Primary completion
- Oct 18, 2014
- Completion
- Nov 7, 2017
- Last update posted
- Dec 5, 2024
2011 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 25
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US1934 | Homewood | Alabama | 35209 | — |
| Site US1527 | Anchorage | Alaska | 99503 | — |
| Site US3026 | Tucson | Arizona | 85715 | — |
| Site US2977 | Highland | California | 92346 | — |
| Site US3630 | San Diego | California | 92123 | — |
| Site US2935 | Denver | Colorado | 80211 | — |
| Site US2945 | Middlebury | Connecticut | 06762 | — |
| Site US2014 | Melrose Park | Illinois | 60160 | — |
| Site US2067 | Springfield | Illinois | 62703 | — |
| Site US2027 | Jeffersonville | Indiana | 47130 | — |
| Site US1838 | West Des Moines | Iowa | 50266 | — |
| Site US62 | Kansas City | Kansas | 66160-7233 | — |
| Site US2976 | Baltimore | Maryland | 21201 | — |
| Site US3182 | Bethesda | Maryland | 20889-5600 | — |
| Site US2975 | Ann Arbor | Michigan | 48109 | — |
| Site US892 | Grand Rapids | Michigan | 49546 | — |
| Site US20 | Minneapolis | Minnesota | 55455 | — |
| Site US3078 | Billings | Montana | 59101 | — |
| Site US2968 | Lawrenceville | New Jersey | 08648 | — |
| Site US3025 | Poughkeepsie | New York | 12601 | — |
| Site US1675 | Rochester | New York | 14642 | — |
| Site US2934 | Staten Island | New York | 10304 | — |
| Site US81 | Chapel Hill | North Carolina | 27599 | — |
| Site US2104 | Greensboro | North Carolina | 27403 | — |
| Site US44 | Cincinnati | Ohio | 45267 | — |
| Site US2185 | Columbus | Ohio | 43221 | — |
| Site US1598 | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Site US1680 | Lancaster | Pennsylvania | 17604 | — |
| Site US2926 | Myrtle Beach | South Carolina | 29572 | — |
| Site US1657 | Nashville | Tennessee | 37209 | — |
| Site US464 | Houston | Texas | 77030 | — |
| Site US2978 | San Antonio | Texas | 78229 | — |
| Site US1653 | Virginia Beach | Virginia | 23462 | — |
| Site US1580 | Burien | Washington | 98166 | — |
| Site US1709 | Wenatchee | Washington | 98801 | — |
| Site US51 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01288911, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2024 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01288911 live on ClinicalTrials.gov.